Citation Impact
2 by Nobel laureates 61 standout
Citing Papers
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
2022 Standout
Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future
2022 Standout
Works of Hoffmann-La Roche being referenced
Ixabepilone plus capecitabine vs capecitabine in patients with triple negative tumors: a pooled analysis of patients from two large phase III clinical studies.
2009
Prediction of Carboplatin Clearance From Standard Morphological and Biological Patient Characteristics
1995
Author Peers
| Author | Oncology | Cancer Research | PRM | PFM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Hoffmann-La Roche | 252 | 123 | 91 | 132 | 14 | 423 | |
| Mupawjay Pimanpanarak | 61 | 3 | 15 | 2 | 32 | 1.0k | |
| Cheng‐Yo Yen | 10 | 20 | 121 | 37 | 726 | ||
| Nnaemeka Arinze Udowelle | 2 | 12 | 1 | 3 | 19 | 343 | |
| Cai Chongyang | 4 | 55 | |||||
| Martin Mocker | 30 | 211 |
All Works
Loading papers...